About me
Lindsey Murray, PhD, MPH, is Executive Director of the Rare Disease Clinical Outcome Assessment (COA) Consortium at C-Path. Dr. Murray has nearly 20 years of experience in clinical and health outcomes research, specializing in quantifying the patient’s perspective of health, illness, and treatment through COA development, psychometric testing, and the design and analysis of clinical trials involving COAs. Her research focus includes capturing and understanding the symptomatic experiences of persons and families with lived experience in pediatric, non-oncological rare diseases through COAs that can support endpoints in clinical trials. In partnership with member firms, she is promoting solutions to methodologic challenges in RD research.
